Peter Traxler
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Organic Chemistry top 2%
- Synthesis and biological activity
- Quinazolinone synthesis and applications
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 13
- Angiogenesis and VEGF in Cancer 4
- Oncology 28
- HER2/EGFR in Cancer Research 21
- Co-authors
- Elisabeth Buchdunger (10 shared papers)Pascal Furet (1 shared paper)Thomas Meyer (11 shared papers)Nicholas Lydon (11 shared papers)Pascal Furet (8 shared papers)Helmut Mett (10 shared papers)Christoph Bock (3 shared papers)Christian Schmidl (1 shared paper)
- Journals
- The Journal of Antibiotics (12 papers)Helvetica Chimica Acta (8 papers)Journal of Medicinal Chemistry (6 papers)Medicinal Research Reviews (3 papers)Cancer Research (2 papers)
- Partner nations
- SwitzerlandUnited StatesAustralia
In The Last Decade
Peter Traxler
61 papers receiving 4.4k citations
Peter Traxler's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.4k
- Organic Chemistry 1.1k
- Molecular Biology 2.5k
- Microbiology 27
- Hematology 324
Countries citing papers authored by Peter Traxler
This map shows the geographic impact of Peter Traxler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Traxler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Traxler more than expected).
Fields of papers citing papers by Peter Traxler
This network shows the impact of papers produced by Peter Traxler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Traxler. The network helps show where Peter Traxler may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Traxler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pooled CRISPR screening with single-cell transcriptome readout Hit paper breakdown → | 2017 | 681 |
| 2 | Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. | 2000 | 422 |
| 3 | 1999 | 325 | |
| 4 | 2004 | 269 | |
| 5 | 2001 | 265 | |
| 6 | 2004 | 265 | |
| 7 | 2005 | 192 | |
| 8 | 2003 | 188 | |
| 9 | 1997 | 185 | |
| 10 | 1996 | 134 | |
| 11 | 1977 | 112 | |
| 12 | 1996 | 105 | |
| 13 | 2000 | 100 | |
| 14 | 1999 | 90 | |
| 15 | 1995 | 90 | |
| 16 | 1990 | 82 | |
| 17 | 1995 | 72 | |
| 18 | 1980 | 68 | |
| 19 | Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. | 2001 | 66 |
| 20 | 1998 | 59 |
About Peter Traxler
Peter Traxler is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Hematology, having authored 61 papers that have together received 4.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (21 papers), PI3K/AKT/mTOR signaling in cancer (13 papers), Microbial Natural Products and Biosynthesis (11 papers), Chronic Myeloid Leukemia Treatments (8 papers), Quinazolinone synthesis and applications (8 papers), Click Chemistry and Applications (6 papers), Actinomycetales infections and treatment (6 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Oncology (1.4k citations), Organic Chemistry (1.1k citations), Molecular Biology (2.5k citations), Microbiology (27 citations) and Hematology (324 citations). Peter Traxler has collaborated with scholars based in Switzerland, United States and Australia. Frequent co-authors include Elisabeth Buchdunger, Pascal Furet, Thomas Meyer, Nicholas Lydon, Pascal Furet, Helmut Mett, Christoph Bock, Christian Schmidl, Donát Alpár and Thomas Krausgruber. Their work appears in journals such as The Journal of Antibiotics, Helvetica Chimica Acta, Journal of Medicinal Chemistry, Medicinal Research Reviews and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.